We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Judge Decertifies Class In Off-Label Neurontin Suit

Law360 (February 11, 2009, 12:00 AM EST) -- A Philadelphia judge has decertified a class in a putative action against Pfizer Inc. over off-label marketing of generic versions of its blockbuster epilepsy drug Neurontin, finding that the class members'...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.